BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 32292501)

  • 1. Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases.
    Wu SS; Li QC; Yin CQ; Xue W; Song CQ
    Theranostics; 2020; 10(10):4374-4382. PubMed ID: 32292501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of CRISPR/Cas Systems for Precise Genome Editing.
    Hryhorowicz M; Lipiński D; Zeyland J
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-mediated correction of human genetic disease.
    Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
    Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
    Zhang X; Wang L; Liu M; Li D
    Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Therapeutic Genome Editing in China.
    Yang Y; Wang Q; Li Q; Men K; He Z; Deng H; Ji W; Wei Y
    Hum Gene Ther; 2018 Feb; 29(2):136-145. PubMed ID: 29446996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy Development by Genome Editing of Hematopoietic Stem Cells.
    Koniali L; Lederer CW; Kleanthous M
    Cells; 2021 Jun; 10(6):. PubMed ID: 34198536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas System: The Current and Emerging Translational Landscape.
    Bhokisham N; Laudermilch E; Traeger LL; Bonilla TD; Ruiz-Estevez M; Becker JR
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the diversity of genetic outcomes from CRISPR-Cas generated homology-directed repair.
    Sansbury BM; Hewes AM; Kmiec EB
    Commun Biol; 2019; 2():458. PubMed ID: 31840103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo somatic cell base editing and prime editing.
    Newby GA; Liu DR
    Mol Ther; 2021 Nov; 29(11):3107-3124. PubMed ID: 34509669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 Editing: Sparking Discussion on Safety in Light of the Need for New Therapeutics.
    Carlaw TM; Zhang LH; Ross CJD
    Hum Gene Ther; 2020 Aug; 31(15-16):794-807. PubMed ID: 32586150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR Genome Editing Technology and its Application in Genetic Diseases: A Review.
    Khatibi S; Sahebkar A; Aghaee-Bakhtiari SH
    Curr Pharm Biotechnol; 2021; 22(4):468-479. PubMed ID: 32564746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 therapeutics for liver diseases.
    Aravalli RN; Steer CJ
    J Cell Biochem; 2018 Jun; 119(6):4265-4278. PubMed ID: 29266637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homology-based repair induced by CRISPR-Cas nucleases in mammalian embryo genome editing.
    Zhang X; Li T; Ou J; Huang J; Liang P
    Protein Cell; 2022 May; 13(5):316-335. PubMed ID: 33945139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Genome Editing by CRISPR/Cas9-Mediated Strategy to Cure Genetic Disorders in Humans: Guide for Molecular Surgeons.
    Ergoren MC; Idlibi R
    Crit Rev Eukaryot Gene Expr; 2019; 29(5):387-399. PubMed ID: 32421996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas-Mediated Base Editing: Technical Considerations and Practical Applications.
    Molla KA; Yang Y
    Trends Biotechnol; 2019 Oct; 37(10):1121-1142. PubMed ID: 30995964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in CRISPR/Cas gene therapy for inborn errors of immunity.
    Liu X; Li G; Liu Y; Zhou F; Huang X; Li K
    Front Immunol; 2023; 14():1111777. PubMed ID: 37051232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas-Based Modifications for Therapeutic Applications: A Review.
    Bharathkumar N; Sunil A; Meera P; Aksah S; Kannan M; Saravanan KM; Anand T
    Mol Biotechnol; 2022 Apr; 64(4):355-372. PubMed ID: 34741732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression and application of CRISPR-Cas genomic editors.
    Yang L; Tang J; Ma X; Lin Y; Ma G; Shan M; Wang L; Yang Y
    Methods; 2021 Oct; 194():65-74. PubMed ID: 33774156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic Principles and Clinical Applications of CRISPR-Based Genome Editing.
    Lim JM; Kim HH
    Yonsei Med J; 2022 Feb; 63(2):105-113. PubMed ID: 35083895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.